Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
NCT06898606Phase 2Recruiting
- Sponsor
- Federal University of Latin American Integration
- Start
- Sep 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in major depressive disorder (MDD), sponsored by Federal University of Latin American Integration. Started Sep 2024; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06898606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06898606.